|1.||Burnstock, Geoffrey: 23 articles (03/2014 - 04/2003)|
|2.||Inoue, Kazuhide: 8 articles (09/2012 - 02/2005)|
|3.||Di Virgilio, Francesco: 6 articles (12/2013 - 11/2006)|
|4.||Idzko, Marco: 5 articles (09/2015 - 08/2008)|
|5.||Salter, Michael W: 5 articles (09/2012 - 01/2005)|
|6.||Tsuda, Makoto: 5 articles (09/2012 - 02/2005)|
|7.||Yamada, Shizuo: 4 articles (01/2014 - 05/2008)|
|8.||Kroemer, Guido: 4 articles (04/2013 - 10/2009)|
|9.||Illes, Peter: 4 articles (01/2013 - 07/2004)|
|10.||Ferrari, Davide: 4 articles (07/2011 - 08/2008)|
|1.||Overactive Urinary Bladder (Overactive Bladder)
11/01/2014 - "Our goal was to examine purinoceptors expression in the ischemic overactive bladder. "
12/01/2006 - "The most important receptors for activation of contraction are muscarinic (M3) and purinergic receptors (P2X1), however, the contribution of these receptors to contraction may differ between species, and may be changed in bladder dysfunction associated with detrusor overactivity (DO) and/or the overactive bladder (OAB) syndrome, such as outflow obstruction, neurogenic bladders, idiopathic DO and diabetes. "
01/01/2015 - "Presence of Cleaved Synaptosomal-Associated Protein-25 and Decrease of Purinergic Receptors P2X3 in the Bladder Urothelium Influence Efficacy of Botulinum Toxin Treatment for Overactive Bladder Syndrome."
07/15/2015 - "eATP activates purinergic receptors in dendritic cells (DCs) and may inhibit inflammation. "
01/01/2015 - "Based on evidence from inflammatory responses in the airways and vasculature and autoimmune complications in humans and rodents, it is beyond doubt that hepatocellular inflammation such as that seen in NASH can result from the activation of purinergic receptors. "
10/01/2014 - "The early events of wound healing, hemostasis, and inflammation are highly regulated by these signals through activation of purinergic receptors on platelets and neutrophils. "
09/10/2014 - "LPS-induced dental pulp inflammation increases expression of ionotropic purinergic receptors in rat trigeminal ganglion."
03/01/2014 - "The upregulation of P2X7-R in CD inflamed mucosa is consistent with the involvement of purinoceptors in inflammation and apoptosis. "
11/01/2014 - "To study the effects of chronic ischemia on bladder purinoceptors. "
10/01/2015 - "These results suggest that the myocardial expression of the protective P2Y2 subtype of purinergic receptors is reduced, whereas that of the harmful subtype P2X7 subtype is increased during coronary ischemia-reperfusion. "
10/01/2015 - "Ischemia-reperfusion reduced the gene expression and protein content of purinergic receptors of the P2Y2 subtype, and increased the gene expression and protein content of the P2X7 subtype. "
11/01/2014 - "Effects of ischemia and oxidative stress on bladder purinoceptors expression."
08/01/2011 - "We investigated the effects of ischemia/reperfusion in the intestine (I/R-i) on purine receptor P2X2-immunoreactive (IR) neurons of the rat ileum. "
05/01/2012 - "Antagonism of P2X3 purinoceptors on pain-conveying nerves is a highly novel approach, and compounds from this class are advancing into patient studies. "
01/01/2012 - "Several of the purinergic receptors have been shown to be important for the development and maintenance of neuropathic and inflammatory pain, and studies have demonstrated the importance of both peripheral and central mechanisms. "
01/01/2013 - "P2X3 receptors (P2XRs), as members of the purine receptor family, are deeply involved in chronic pain sensation and therefore, specific, competitive antagonists are of great interest for perspective pain management. "
12/03/2012 - "Intercellular communication in sensory ganglia by purinergic receptors and gap junctions: implications for chronic pain."
04/01/2012 - "A predicted therapeutic benefit of interfering with microglial purinergic receptors may be that normal pain sensitivity would be unaffected since expression or activity of most of these receptors are upregulated or enhanced predominantly in activated microglia in the spinal cord where damaged sensory fibers project."
|1.||Botulinum Toxins (Botulinum Toxin)
|2.||Adenosine Triphosphate (ATP)
|4.||Suramin (Suramin Sodium)
|5.||Adenosine Diphosphate (ADP)
|6.||Purinergic P1 Receptors (Adenosine Receptor)
|7.||Type C Phospholipases
|8.||Adenylate Cyclase (Adenylyl Cyclase)
|9.||Purinergic P2X7 Receptors
|10.||Adrenergic Receptors (Adrenergic Receptor)